Clostridioides difficile remains an important public health threat, globally. Since the
emergence of the hypervirulent strain, ribotype 027, new strains have been reported to …

Resistance to antimicrobials and particularly multidrug resistance is one of the greatest
challenges in the health system nowadays. The continual increase in the rates of …

Clostridioides species possess many virulence factors and alarming levels of muti-drug
resistance which make them a significant risk to public health safety and a causative agent …

Therapeutic bacteriophages (phages) are being considered as alternatives in the fight
against Clostridioides difficile infections. To be efficient, phages should have a wide host …

Clostridioides difficile is considered a nosocomial pathogen that flares up in patients
exposed to antibiotic treatment. However, four out of ten patients diagnosed with C. difficile …

Clostridium perfringens is a gram-positive, anaerobic, and spore-forming bacterium that
produces toxins causing various diseases in humans and livestock animals. With the growth …

Clostridioides difficile (C. difficile) infection (CDI) is the most common hospital-acquired
infection. With the combination of a high rate of antibiotic resistance and recurrence, it has …

The global trend towards raising broiler chickens without the use of in-feed antibiotics (IFAs)
means that there is an ongoing need to develop alternative treatments capable of delivering …

Up to 25% of patients recovering from antibiotic-treated Clostridioides difficile infection (CDI)
develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI …

Bacteriophages have the potential to eliminate both antibiotic-resistant and sensitive
bacteria; as a result, they have become a major focus of such research. In contrast to …